Project: 101156555

Project name:	SGLT2-HYPE - SGLT2 inhibition for cardiovascular endpoint reduction in hypertension
Project code:	101156555
Proposing institution/Lead promoter/Coordinating entity:	Universitatsklinikum Schleswig-Holstein
Partner(s)/Co-promoter(s)/Participating institution(s):	ARTTIC Innovation GmbH; Bogomolets National Medical University; Deutsche Gesellschaft für Kardiologie - Herz- und Kreislau; DEUTSCHE HERZSTIFTUNG EV; Faculdade de Medicina da Universidade do Porto; General Practitioners Research Institute; Institut National de la Santé et de la Recherche Médicale - INSERM; INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ; IRCCS AZIENDA OSPEDALIERO- UNIVERSITARIA DI BOLOGNA; Medizinische Universität Innsbruck; NARODOWY INSTYTUT KARDIOLOGII STEFANA KARDYNALA WYSZYNSKIEGO - PANSTWOWY INSTYTUT BADAWCZY; STIFTUNG INSTITUT FUR HERZINFARKTFORSCHUNG LUDWIGSHAFEN; UNIVERSITAET zu LUEBECK; University of Glasgow; UNIVERZITETNI KLINICNI CENTER LJUBLJANA; Vilniaus universiteto ligonine Santaros klinikos; Vseobecná fakultní nemocnice v Praze
Start date:	2025-01-01
Completion date:	2032-06-30

Eligible Cost of the Project

Total Eligible Cost:	6.999.998,90 EUR
Eligible Cost in the University of Porto:	126.938,75 EUR
Faculdade de Medicina da Universidade do Porto:	126.938,75 EUR